Scientists develop DNA-delivered immunotherapy that targets ovarian cancer more effectively - Medical Xpress
Scientists develop DNA-delivered immunotherapy that targets ovarian cancer more effectively Medical Xpress
Ovarian Cancer News
Many Ovarian Cancer Diagnoses Occur After Emergency Admission - Oncology Nurse Advisor
Many Ovarian Cancer Diagnoses Occur After Emergency Admission Oncology Nurse Advisor
J&J Asks Court to Dismiss All 67,000 Ovarian Cancer Talc Lawsuits - Mesothelioma.net
J&J Asks Court to Dismiss All 67,000 Ovarian Cancer Talc Lawsuits Mesothelioma.net
Richard Simcock: Emergency Diagnosis Remains a Major Challenge in Ovarian Cancer Care - Oncodaily
Richard Simcock: Emergency Diagnosis Remains a Major Challenge in Ovarian Cancer Care Oncodaily
‘She left us with a beautiful legacy’: Family honors North Reading teen lost to ovarian cancer - Boston 25 News
‘She left us with a beautiful legacy’: Family honors North Reading teen lost to ovarian cancer Boston 25 News
Nearly half of ovarian cancer cases are diagnosed in ER, missing critical treatment window, study finds - ABC News - Breaking News, Latest News and Videos
Nearly half of ovarian cancer cases are diagnosed in ER, missing critical treatment window, study finds ABC News - Breaking News, Latest News and Videos
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium - Nature
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium Nature
Ovarian Cancer: Can Repurposed Drugs Work Better Together? - Medscape
Ovarian Cancer: Can Repurposed Drugs Work Better Together? Medscape
The Symptoms Of Ovarian Cancer Are Easy To Dismiss — What To Watch For - MindBodyGreen
The Symptoms Of Ovarian Cancer Are Easy To Dismiss — What To Watch For MindBodyGreen
MSU Researchers Discover New Target to Overcome Ovarian Cancer Chemotherapy Resistance - Michigan State University
MSU Researchers Discover New Target to Overcome Ovarian Cancer Chemotherapy Resistance Michigan State University
Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain - MedCity News
Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain MedCity News
One in five relatives of breast and ovarian cancer patients in Estonia carry dangerous cancer-linked genes, study shows - Frontiers
One in five relatives of breast and ovarian cancer patients in Estonia carry dangerous cancer-linked genes, study shows Frontiers
A common cholesterol drug may weaken ovarian cancer defenses - Duke School of Medicine
A common cholesterol drug may weaken ovarian cancer defenses Duke School of Medicine
ESMO Updates Ovarian Cancer Guidelines: What Has Changed? - Oncology News Central
ESMO Updates Ovarian Cancer Guidelines: What Has Changed? Oncology News Central
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026 - PR Newswire
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026 PR Newswire
How Chemotherapy Reshapes Ovarian Cancer: New Insights From Tumor Profiling - Oncodaily
How Chemotherapy Reshapes Ovarian Cancer: New Insights From Tumor Profiling Oncodaily
Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use - Nature
Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use Nature
The ovarian cancer drug market - Nature
The ovarian cancer drug market Nature
Stephanie Nougaret: Proud to Be Part of an Exceptional Ovarian Cancer Care Team - Oncodaily
Stephanie Nougaret: Proud to Be Part of an Exceptional Ovarian Cancer Care Team Oncodaily
Rethinking ovarian cancer III: the past decade and future directions - Nature
Rethinking ovarian cancer III: the past decade and future directions Nature
Scientists uncover how ovarian cancer resists chemotherapy—and how to reverse it - Medical Xpress
Scientists uncover how ovarian cancer resists chemotherapy—and how to reverse it Medical Xpress
Can ovarian cancer screening work? A secondary analysis of the UK collaborative trial of ovarian cancer screening - Nature
Can ovarian cancer screening work? A secondary analysis of the UK collaborative trial of ovarian cancer screening Nature
ROSELLA Trial: New Ovarian Cancer Treatment Shows Survival Benefit - Oncology News Central
ROSELLA Trial: New Ovarian Cancer Treatment Shows Survival Benefit Oncology News Central
For First Time, Definitive Standard Established for Low-Grade Serous Ovarian Carcinoma - Oncology News Central
For First Time, Definitive Standard Established for Low-Grade Serous Ovarian Carcinoma Oncology News Central
Tennis legend Chris Evert says she has ovarian cancer for the 3rd time. It's not as rare as it sounds. - Yahoo Health
Tennis legend Chris Evert says she has ovarian cancer for the 3rd time. It's not as rare as it sounds. Yahoo Health
Sofetabart Mipitecan Hits 50% Response Rate in Platinum-Resistant Ovarian Cancer - Targeted Oncology
Sofetabart Mipitecan Hits 50% Response Rate in Platinum-Resistant Ovarian Cancer Targeted Oncology
4 ovarian cancer candidates to watch: GSK, Allarity and more - BioSpace
4 ovarian cancer candidates to watch: GSK, Allarity and more BioSpace
Why women with ovarian cancer should consider clinical trials - Roswell Park Comprehensive Cancer Center
Why women with ovarian cancer should consider clinical trials Roswell Park Comprehensive Cancer Center
Cancer survivor completes mountain trek - Fox 59
Cancer survivor completes mountain trek Fox 59
Robotic Surgery May Improve Key Outcomes in Advanced Ovarian Cancer, But Evidence Still Limited - Docwire News
Robotic Surgery May Improve Key Outcomes in Advanced Ovarian Cancer, But Evidence Still Limited Docwire News
Christine Campbell։ Successful Meeting With Target Ovarian Cancer as Part of NIAction Team - Oncodaily
Christine Campbell։ Successful Meeting With Target Ovarian Cancer as Part of NIAction Team Oncodaily
ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer | Oncogene - Nature
ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer | Oncogene Nature
Olympic Ice Dancer Piper Gilles Survived Ovarian Cancer. Here’s What to Know About the Disease. - University of Colorado Anschutz
Olympic Ice Dancer Piper Gilles Survived Ovarian Cancer. Here’s What to Know About the Disease. University of Colorado Anschutz
Dr. Sandra Orsulic awarded $1.9M in grants to advance ovarian cancer research - UCLA Health
Dr. Sandra Orsulic awarded $1.9M in grants to advance ovarian cancer research UCLA Health
Clinicopathological Spectrum of Ovarian Tumors and Diagnostic Utility of Cancer Antigen 125 (CA-125): An Observational Study From Eastern India - Cureus
Clinicopathological Spectrum of Ovarian Tumors and Diagnostic Utility of Cancer Antigen 125 (CA-125): An Observational Study From Eastern India Cureus
Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment - UC San Diego Today
Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment UC San Diego Today
Imaging in Advanced Epithelial Ovarian Cancer: Assessment of Peritoneal Spread - RSNA Journals
Imaging in Advanced Epithelial Ovarian Cancer: Assessment of Peritoneal Spread RSNA Journals
What Was 2025’s Biggest News in Ovarian Cancer? - Oncology News Central
What Was 2025’s Biggest News in Ovarian Cancer? Oncology News Central
Zentalis Pharmaceuticals Announces ESMO 2026 Rapid Oral Presentation of DENALI Overall Survival Data for Azenosertib in Platinum-Resistant Ovarian Cancer - Quiver Quantitative
Zentalis Pharmaceuticals Announces ESMO 2026 Rapid Oral Presentation of DENALI Overall Survival Data for Azenosertib in Platinum-Resistant Ovarian Cancer Quiver Quantitative
Ovarian cancer survivor: ‘I wish I’d gone to UT MD Anderson first’ - UT MD Anderson
Ovarian cancer survivor: ‘I wish I’d gone to UT MD Anderson first’ UT MD Anderson